A Phase II, Randomized Study of T DM1 versus T DM1 plus short induction with docetaxel in first line treatment for locally advanced or metastatic HER2+ breast cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2014
At a glance
- Drugs Trastuzumab emtansine (Primary) ; Docetaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 Oct 2014 New trial record